News | September 28, 2010

Device to Treat Refractory Angina Featured in Live Case at TCT

September 28, 2010 – The Transcatheter Cardiovascular Therapeutics (TCT) 2010 symposium featured a live case broadcast of a physician implanting a new device to treat refractory angina.

At the Antwerp Cardiovascular Institute/ZNA Middelheim in Belgium, Stefan Verheye, M.D., successfully implanted the Neovasc Reducer in the patient’s coronary sinus. Verheye is the principal investigator in the COSIRA study, designed to assess the efficacy of Neovasc’s implantable Reducer device as a treatment for refractory angina.

Refractory angina is a painful and debilitating condition that occurs when the coronary arteries deliver an inadequate blood supply to the heart muscle.

The reducer is implanted in the coronary sinus vein using a minimally invasive percutaneous procedure that is similar to implanting a coronary stent and takes about 20 minutes. It is intended to provide relief by altering blood flow to the coronary sinus, thereby increasing perfusion of oxygenated blood to certain areas of the heart muscle

For more information: www.neovasc.com

Related Content

Medtronic Announces Global Resolute Onyx DES One-Month DAPT Study
News | Antiplatelet and Anticoagulation Therapies| August 18, 2017
Medtronic plc announced a global randomized clinical trial that will evaluate one-month dual antiplatelet therapy (DAPT...
Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
CMS considers eliminating cardiac bundled payments.
Feature | Business| August 16, 2017 | Dave Fornell
August 16, 2017 — The Centers for Medicare and Medicaid Services (CMS) announced a proposed rule to reduce the number
ESC 2017 late breaking trial hot line study presentations.
News | Clinical Study| August 16, 2017
Aug. 16, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking Clinic
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Abbott Initiates First Clinical Trial of Clip-Based Tricuspid Repair System
News | Heart Valve Technology| August 09, 2017
Abbott announced that the first patient has been enrolled in a clinical study to evaluate a minimally invasive clip-...
Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on HeartFlow FFRct Analysis
News | FFR Catheters| August 09, 2017
HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical policy for the...
Overlay Init